Umang Arora

580 total citations
38 papers, 132 citations indexed

About

Umang Arora is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Umang Arora has authored 38 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Surgery and 11 papers in Hepatology. Recurrent topics in Umang Arora's work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Inflammatory Bowel Disease (5 papers). Umang Arora is often cited by papers focused on Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Inflammatory Bowel Disease (5 papers). Umang Arora collaborates with scholars based in India, United States and Singapore. Umang Arora's co-authors include Saurabh Kedia, Vineet Ahuja, S. Shalimar, Swati Jain, Sagnik Biswas, Anshuman Elhence, Ashwin N. Ananthakrishnan, Amit Goel, Ramesh Kumar and Shweta Kumari and has published in prestigious journals such as The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Umang Arora

29 papers receiving 125 citations

Peers

Umang Arora
Adel Alqutub Saudi Arabia
Dalila Costa Portugal
José María Palazón Spain
Г. В. Волынец Russia
John Bate Australia
Yan-yan Yu China
S Vázquez Mexico
Xuefu Wu China
Muhammad Ali Muzammil Pakistan
P. Seliverstov Russia
Adel Alqutub Saudi Arabia
Umang Arora
Citations per year, relative to Umang Arora Umang Arora (= 1×) peers Adel Alqutub

Countries citing papers authored by Umang Arora

Since Specialization
Citations

This map shows the geographic impact of Umang Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umang Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umang Arora more than expected).

Fields of papers citing papers by Umang Arora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umang Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umang Arora. The network helps show where Umang Arora may publish in the future.

Co-authorship network of co-authors of Umang Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Umang Arora. A scholar is included among the top collaborators of Umang Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umang Arora. Umang Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biswas, Sagnik, et al.. (2025). Immune Checkpoint Inhibitor in Hepatocellular Carcinoma: Response Rates, Adverse Events, and Predictors of Response. Journal of Clinical Medicine. 14(3). 1034–1034. 2 indexed citations
2.
Biswas, Sagnik, Anuradha Sharma, Umang Arora, et al.. (2025). Endovascular Interventions for the Secondary Prophylaxis of Gastric Varices Prevent Rebleeding but May Not Improve Overall Survival: A Real-world Cohort From Two Centers. Journal of Clinical and Experimental Hepatology. 16(2). 103416–103416.
3.
Biswas, Sagnik, et al.. (2025). Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk Factor. Journal of Clinical and Experimental Hepatology. 15(5). 102559–102559.
4.
Biswas, Sagnik, Umang Arora, Ayush Agarwal, et al.. (2025). Efficacy, Safety and Long-Term Clinical Outcomes of Low-Dose Versus High-Dose Prednisolone Induction in Autoimmune Hepatitis: A Propensity Score-Matched Analysis. Digestive Diseases and Sciences. 70(9). 3135–3144.
5.
6.
Biswas, Sagnik, Umang Arora, Ayush Agarwal, et al.. (2024). Definitions, Etiologies, and Outcomes of Acute on Chronic Liver Failure: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 22(11). 2199–2210.e25. 10 indexed citations
7.
Biswas, Sagnik, Umang Arora, Anshuman Elhence, et al.. (2024). Thromboelastography-Guided versus Standard-of-Care or On-Demand Platelet Transfusion in Patients with Cirrhosis and Thrombocytopenia Undergoing Procedures: A Randomized Controlled Trial. Journal of Vascular and Interventional Radiology. 35(10). 1508–1518.e2. 2 indexed citations
8.
Biswas, Sagnik, Abhinav Anand, Umang Arora, et al.. (2024). Comparison of 1‐day versus 3‐day intravenous terlipressin in cirrhosis patients with variceal bleeding: A pilot randomised controlled trial. Alimentary Pharmacology & Therapeutics. 59(5). 645–655. 7 indexed citations
9.
Biswas, Sagnik, Shivanand Gamanagatti, Umang Arora, et al.. (2024). Endoscopic Glue Injection vs Glue Plus BRTO or TIPSS for Preventing Gastric Variceal Bleeding: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 23(6). 954–964.e10. 1 indexed citations
10.
Arora, Umang, Syed Sayeed Ahmed, Ashu Seith Bhalla, et al.. (2024). Combined or High Dose Immunosuppression in Inflammatory Bowel Disease patients who are NUDT15 Homozygous Harbors Risk of Developing Invasive Fungal Infections: A Case Series. Inflammatory Bowel Diseases. 30(9). 1623–1625.
11.
Vuyyuru, Sudheer K., Bhaskar Kante, Peeyush Kumar, et al.. (2024). A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn’s Disease. Stem Cell Research & Therapy. 15(1). 140–140. 10 indexed citations
12.
Anand, Abhinav, S. Shalimar, Umang Arora, et al.. (2023). ABDA Score: A Non-invasive Model to Identify Subjects with Fibrotic Non-alcoholic Steatohepatitis in the Community. Journal of Clinical and Experimental Hepatology. 13(5). 742–752. 3 indexed citations
13.
Biswas, Sagnik, Abhinav Anand, Umang Arora, et al.. (2023). Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding. Diagnostics. 13(14). 2385–2385. 2 indexed citations
14.
Arora, Umang, Saurabh Kedia, & Vineet Ahuja. (2023). The practice of fecal microbiota transplantation in inflammatory bowel disease. Intestinal Research. 22(1). 44–64. 11 indexed citations
15.
Arora, Umang, Sagnik Biswas, Soumya Sarkar, et al.. (2023). Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis. Journal of Clinical and Experimental Hepatology. 14(2). 101291–101291. 7 indexed citations
16.
Arora, Umang, Sagnik Biswas, Bhaskar Thakur, et al.. (2022). Therapeutic plasma‐exchange improves short‐term, but not long‐term, outcomes in patients with acute‐on‐chronic liver failure: A propensity score‐matched analysis. Journal of Clinical Apheresis. 38(4). 376–389. 11 indexed citations
17.
Wig, Naveet, Anjan Trikha, Puneet Khanna, et al.. (2022). Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience. Indian Journal of Critical Care Medicine. 26(4). 530–532. 1 indexed citations
18.
Arora, Umang, et al.. (2021). COVID-19 and multi-system inflammatory syndrome in children: keep a high index of suspicion in all inflammatory disorders. International Journal of Contemporary Pediatrics. 8(4). 747–747. 1 indexed citations
19.
Arora, Umang, et al.. (2020). IoT Based Biometric Attendance System. SSRN Electronic Journal. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adel Alqutub Breakdown of academic impact, for papers by Dalila Costa Breakdown of academic impact, for papers by José María Palazón Breakdown of academic impact, for papers by Г. В. Волынец Breakdown of academic impact, for papers by John Bate Breakdown of academic impact, for papers by Yan-yan Yu Breakdown of academic impact, for papers by S Vázquez Breakdown of academic impact, for papers by Xuefu Wu Breakdown of academic impact, for papers by Muhammad Ali Muzammil Breakdown of academic impact, for papers by P. Seliverstov
Rankless by CCL
2026